Flecainide in Atrial Fibrillation is Safe and Effective Shows Study

by Dr. Seema Alavi on  April 23, 2011 at 12:12 PM Health In Focus   - G J E 4
The primary aim of this study was to review the significance of the literature related to the safety, efficacy and the pharmacological characteristics of an old drug that has been around for twenty five years (flecainide) in treating atrial fibrillation.
Flecainide in Atrial Fibrillation is Safe and Effective Shows Study
Flecainide in Atrial Fibrillation is Safe and Effective Shows Study

Normally the heart contracts and pumps at a regular rhythm but in atrial fibrillation one of the chambers of the heart called the atrium, beats faster than the other chambers and results in an abnormal heart rhythm. This abnormal rhythm makes the pumping of the heart inefficient. Atrial Fibrillation (AF) among all the arrhythmias is the most prevalent and is showing an increase in its frequency. Atrial fibrillation is recurrent if patient has experienced two or more attacks.

The condition is often asymptomatic but may result in palpitations, chest pains, congestive heart failure or clot formation with a risk of its migration to other parts of the body.

The long- term sustainable restoration of sinus rhythm (SR) has been well recognized with use of the drug Flecainide. However most doctors still avoid using the drug in treating these abnormal rhythm (or arrhythmia) and this has been due to the increased mortality attributed to this drug that was published in 1991 in a study called Cardiac Arrhythmia Suppression Trial (CAST)..

However the current research shows that it is safe to use this drug in AF provided the patient with AF has no left ventricular disease or coronary heart disease.

Avoiding the use of this useful drug denies the patients of an important treating alternative. Hence it is now suggested that Flecainide should be the first drug of choice to restore sinus rhythm in patients with atrial fibrillation


The study was conducted byEtienne Aliot; Alessandro Capucci; Harry J. Crijns; Andreas Goette; Juan Tamargo pubished in Europace on 02/13/2011

Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
I find it interesting that the medical community's first response to dealing with issues such as 'afib' would be to hand out drugs! In 8 years of testing, I've found that the main culprit in afib and general palpitations is inflammation. Of course all doctors know that inflammation is at the root of most ails. However, they appear afraid to take on their masters in the pharmaceutical industry. If you cure inflammation, you will nearly bankrupt "big pharma" - and they are already beginning to suffer growing declines. I'm not saying that all afib results from inflammation. Those with a prolapsed mitral valve will certain have afib issues. But for most of us, the cause usually traces back to inflammation. To fix this, you must increase your alkalinity.
lucidboomer Sunday, May 15, 2011

You May Also Like

View All